• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Invivyd, Inc. - Common Stock (NQ: IVVD )

    1.250 +0.030 (+2.46%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 214,816
    Open 1.220
    Bid (Size) 1.220 (20)
    Ask (Size) 1.250 (39)
    Prev. Close 1.220
    Today's Range 1.215 - 1.280
    52wk Range 1.050 - 5.195
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Invivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes
    From Invivyd
    Via GlobeNewswire
    Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 Variants
    From Invivyd
    Via GlobeNewswire

    Performance

    YTD
    -65.75%
    -65.75%
    1 Month
    -1.57%
    -1.57%
    3 Month
    -42.92%
    -42.92%
    6 Month
    -72.22%
    -72.22%
    1 Year
    -10.71%
    -10.71%

    More News

    Read More
    Invivyd to Participate at the Jefferies Global Healthcare Conference
    From Invivyd
    Via GlobeNewswire
    IVVD Stock Earnings: Invivyd Meets EPS for Q1 2024
    Via InvestorPlace
    IVVD Stock Earnings: Invivyd Misses EPS for Q4 2023
    Via InvestorPlace
    Invivyd: Q4 Earnings Insights
    Via Benzinga
    Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial
    From Invivyd
    Via GlobeNewswire
    Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer
    From Invivyd
    Via GlobeNewswire
    Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)
    From Invivyd
    Via GlobeNewswire
    Invivyd Elects Two New Independent Members to its Board of Directors
    From Invivyd
    Via GlobeNewswire
    Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
    From Invivyd
    Via GlobeNewswire
    Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
    From Invivyd
    Via GlobeNewswire
    Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback
    From Invivyd
    Via GlobeNewswire
    Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights
    From Invivyd
    Via GlobeNewswire
    Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position
    From Invivyd
    Via GlobeNewswire
    Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™
    From Invivyd
    Via GlobeNewswire
    Invivyd Announces CEO Transition
    From Invivyd
    Via GlobeNewswire
    Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million
    From Invivyd
    Via GlobeNewswire
    Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
    From Invivyd
    Via GlobeNewswire
    Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.